Phytanic acid, but not pristanic acid, mediates the positive effects of phytol derivatives on brown adipocyte differentiation  by Schluter, Agatha et al.
Phytanic acid, but not pristanic acid, mediates the positive e¡ects of
phytol derivatives on brown adipocyte di¡erentiation
Agatha Schluter, Marta Giralt, Roser Iglesias, Francesc Villarroya
Departament de Bioqu|¤mica i Biologia Molecular, Universitat de Barcelona, Avinguda Diagonal 645, E-08028 Barcelona, Spain
Received 11 February 2002; accepted 12 March 2002
First published online 25 March 2002
Edited by Jacques Hanoune
Abstract The phytol derivatives phytanic acid and pristanic
acid may activate nuclear hormone receptors and influence gene
expression and cell differentiation. Phytanic acid induces brown
adipocyte differentiation. It was determined that brown fat and
brown adipocytes are sites of high gene expression of phytanoyl-
CoA hydroxylase, the enzyme required for initiation of
peroxisomal K-oxidation of phytanic acid. However, the effects
of phytanic acid were not mediated by its K-oxidation product
pristanic acid, which did not promote brown adipocyte differ-
entiation or stimulate transcription of the uncoupling protein-1
gene. Moreover, acute cold exposure of mice caused a dramatic
mobilization of the phytanic acid stores in brown adipose tissue
thus suggesting that a high local exposure to phytanic acid in
brown fat may contribute to signalling adaptive changes in the
tissue in response to thermogenic activation. ß 2002 Federa-
tion of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Phytanic acid (3,7,11,15-tetramethylhexadecanoic acid) is a
methyl-branched fatty acid that originates from the phytol
side of the chain of chlorophyll. Phytanic acid enters the hu-
man body in foods such as dairy products or other ruminant
fats. Even though humans cannot release phytol from chloro-
phyll, they can convert it into phytanic acid [1]. The metabo-
lism of phytanic acid begins with activation to phytanoyl CoA
followed by peroxisomal K-oxidation. The ¢rst enzyme in the
K-oxidation pathway of phytanic acid is phytanoyl-CoA hy-
droxylase (PhyH), de¢ciency of which leads to Refsum dis-
ease, an inherited disorder characterized by the accumulation
of phytanic acid [2]. The product of phytanic acid K-oxidation
is pristanic acid (2,6,10,14-tetramethylpentadecanoic acid)
which can also enter humans or rodents in the diet. Pristanic
acid is oxidized by three cycles of peroxisomal L-oxidation,
and the products are exported to mitochondria for further
L-oxidation in a transport pathway that involves peroxisomal
carnitine octanoyl transferase (COT) [3].
Phytanic acid can bind and activate at least two types of
nuclear hormone receptors, retinoid X receptors (RXR) [4,5]
and peroxisome proliferator-activated receptor (PPAR)K [6],
with a⁄nities lower than other ligands but in the range of the
physiological levels of this fatty acid in blood. Pristanic acid
can also activate PPARK [7]. We have recently reported that
phytanic acid, when added to cell culture medium, is an acti-
vator of brown adipocyte di¡erentiation and transcription of
the uncoupling protein-1 (UCP1) gene, the speci¢c marker of
brown adipocytes [8]. Therefore, phytanic acid may a¡ect
adaptive thermogenesis and energy expenditure. As brown
adipose tissue has a high peroxisome content, we hypothesized
that phytanic acid metabolism in this cell type is highly regu-
lated and that the action of phytanic acid is exerted, in whole
or in part, through a product of its metabolism like pristanic
acid. In this study we determined the gene expression of
PhyH, the speci¢c enzyme needed for phytanic acid metabo-
lism, and we assessed the relative capacities of phytanic acid
and pristanic acid to a¡ect brown adipocyte di¡erentiation.
Measurement of phytanic acid in brown fat was performed to
gain insight into the potential physiological signi¢cance of our
¢ndings.
2. Materials and methods
Phytanic acid and nonadecanoic acid were from Sigma (St. Louis,
MO, USA). Pristanic acid was a kind gift of Dr. M. Giro¤s (Institut de
Bioqu|¤mica Cl|¤nica, Barcelona, Spain). Tissue culture media, fetal calf
serum (FCS) and supplements were from BioWhittaker (Walkersville,
MD, USA) and Sigma.
Swiss mice were fed a standard diet (B.K. Universal, Barcelona,
Spain) with a phytanic acid content of 0.645 Wg/g. Adult mice (8 weeks
old) were kept in standard conditions of light (12-h light/12-h dark)
cycle and temperature (21 þ 1‡C). One group of animals was exposed
to 4‡C for 4 h. Mice were killed by decapitation and interscapular
brown adipose tissue, perigonadal white adipose tissue and the liver
were dissected and frozen. Brown preadipocytes were isolated from
3-week-old mice and seeded for primary cultures as described [9].
When brown preadipocytes were grown in Dulbecco’s modi¢ed Ea-
gle’s medium:Ham’s F12 medium (DMEM/F12) (1:1) supplemented
with 10% FCS, 20 nM insulin, 2 nM T3 and 1 WM ascorbate (di¡er-
entiating medium), 85^90% cells were di¡erentiated to brown adipo-
cytes 7^8 days after plating. When indicated, cells were grown after
day 3 of culture in a medium containing 10% charcoal-stripped, deli-
pidated calf bovine serum (Sigma), which blocked brown adipocyte
di¡erentiation (non-di¡erentiating medium). The content of phytanic
acid in ‘di¡erentiating medium’ resulting from 10% FCS was 0.01 WM
but it was not detected in the ‘non-di¡erentiating’ medium. The HIB-
1B brown adipocyte cell line was cultured in DMEM/F12 containing
10% heat-inactivated FCS. For treatment, phytanic acid and pristanic
0014-5793 / 02 / $22.00 ß 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 2 ) 0 2 5 8 3 - 8
*Corresponding author.
E-mail address: gombau@porthos.bio.ub.es (F. Villarroya).
Abbreviations: PhyH, phytanoyl-CoA hydroxylase; RXR, retinoid X
receptor; PPAR, peroxisome proliferator-activated receptor; FCS, fe-
tal calf serum; DMEM, Dulbecco’s modi¢ed Eagle’s medium; COT,
carnitine octanoyl transferase; UCP1, uncoupling protein-1; CAT,
chloramphenicol acetyltransferase
FEBS 25988 12-4-02
FEBS 25988 FEBS Letters 517 (2002) 83^86
acid were dissolved in dimethylsulfoxide and the corresponding con-
trols included equivalent amounts of the solvent, always at a ¢nal
proportion of less than 1:1000 in the culture medium.
RNA from brown adipocytes in primary culture and from tissue
was extracted following an a⁄nity column-based method (RNeasy,
Qiagen, Hilden, Germany). 10 Wg RNA was used for Northern blot
analysis, as reported [9]. For detection of PhyH mRNA, a probe was
obtained after coupled reverse transcription and PCR ampli¢cation of
mouse liver RNA using the primers 5P-GCAGTTTCGTCTGCTG-
GCC-3P and 5P- GTACCTCACTCTTGAAGGGC-3P, which corre-
spond to positions 14^29 and 1080^1061 in the PhyH cDNA sequence
(GenBank AF023463). Reactions were performed using 5 Wg of RNA
from mouse liver, 1 WM each primer, 2 WM each of the four nucleotide
triphosphates, 3 mM MgSO4, 0.1 U/Wl Thermus £avus DNA polymer-
ase and the AMV/T£ as provided by the supplier (Promega, Madison,
WI, USA). After 1 h incubation at 48‡C, 40 cycles were performed,
each at 94‡C, 30 s, 55‡C, 2 min, and 68‡C, 1 min. The resulting DNA
product, of approximately 1.8 kb, was puri¢ed, cloned into vector
pGEM-T and sequenced. Other DNA probes used were the rat
cDNA for COT [10], the rat cDNA for UCP1 [11] and the murine
cDNA for aP2 [12]. The DNA probes were labeled with [K-32P]dCTP
following the random oligonucleotide primer method. Hybridization
signals were quanti¢ed using a Molecular Image System GS-525 (Bio-
Rad, Hercules, CA, USA).
The plasmid 4.5UCP1-CAT, in which the region 34551 to +110 of
the rat ucp-1 gene drives the chloramphenicol acetyltransferase (CAT)
reporter gene, and expression vectors for human RXRK (pSG5^RXR)
and mouse PPARK (pSG5^PPARK) were used. HIB-1B cells were
transfected using the FuGENE Transfection Reagent (Roche Diagnos-
tics, Indianapolis, IN, USA) for 16 h, exposed to phytanic acid or
pristanic acid and harvested 24 h later. Each transfection solution
contained 0.5 Wg of UCP1^CAT vector and 0.1 Wg of cytomegolavi-
rus^L-galactosidase, with or without 0.05 Wg of expression vector.
CAT activity was analyzed as reported [13] and it was normalized
for variation in transfection e⁄ciency using the L-galactosidase activ-
ity measured for each sample.
For phytanic acid quanti¢cation, total lipid extraction was per-
formed on brown adipose tissue by the hexane/isopropanol method
[14]. Tissue extracts or serum were directly transmethylated [15] in the
presence of nonadecanoic acid as internal standard. Phytanic acid
methyl ester was analyzed by gas chromatography on a DB-7 1701
column (JpW Scienti¢c) and the peak area was used for quanti¢ca-
tion followed by normalization using the internal standard. Retention
times for the corresponding methyl esters and standards for phytanic
acid quanti¢cation were established in parallel. To check the major
lipid fraction containing phytanic acid, lipid extracts were subjected to
thin-layer chromatography in silica gel plates using hexane/diethyl
ether/acetic acid (80:20:1, v/v) as a mobile phase. The triacylglycerol
fraction was separated from the other lipid fractions, extracted with
chloroform/methanol (2:1, v/v), transesteri¢ed and analyzed by gas
chromatography as reported above.
3. Results
3.1. PhyH mRNA is highly expressed in brown adipose tissue
and di¡erentiated brown adipocytes
Fig. 1 shows the mRNA expression for PhyH, the speci¢c
enzyme for initiation of phytanic acid oxidation, in brown
adipose tissue compared with liver and white adipose tissue.
The expression of PhyH mRNA in brown adipose tissue was
even higher than in liver whereas expression in white fat was
very low. Brown adipocytes di¡erentiated in culture also
showed high expression of PhyH mRNA, which was dramat-
ically reduced when cells were prevented from di¡erentiating
by a delipidated culture medium. PhyH mRNA levels recov-
ered partially following the treatment with phytanic acid. This
pattern of regulation of expression was similar to marker
genes for brown adipocyte di¡erentiation such as UCP1
mRNA or aP2 mRNA. However, the positive e¡ects of di¡er-
entiation on PhyH mRNA were not common to gene expres-
sion for other peroxisomal proteins. Thus, the expression of
Fig. 1. Expression of PhyH mRNA in murine brown and white adipose tissues, liver and di¡erentiating brown adipocytes in culture. Northern
blot analysis of 10 Wg RNA (A) from the interscapular brown adipose tissue (BAT), perigonadal white adipose tissue (WAT), liver from the
adult mouse and (B) from brown adipocyte cells cultured in conditions leading to di¡erentiation (Di¡erentiated), to non-di¡erentiation due to
culture in delipidated medium (Non-di¡erentiated) and conditions of supplementation of delipidated medium with 10 WM phytanic acid (Non-
di¡erentiated+Phytanic). The size of the detected transcripts is shown to the right.
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mRNA for COT, a peroxisomal enzyme involved in the ex-
port of products of fatty acid peroxisomal oxidation to mito-
chondria, was not a¡ected by the di¡erentiation status of the
brown fat cell or by supplementation with phytanic acid.
3.2. E¡ects of pristanic acid and phytanic acid on brown
adipocyte di¡erentiation
Considering the positive e¡ect of phytanic acid on brown
adipocyte di¡erentiation and the high expression of PhyH in
these cells, the e¡ects of pristanic acid were tested. For this
purpose, brown adipocyte precursor cells were cultured in
‘non-di¡erentiating’ medium and the capacity of pristanic
acid to induce cells to di¡erentiate was compared to that
of phytanic acid supplementation. Pristanic acid was more
toxic to primary brown preadipocyte cultures than phytanic
acid. Thus, whereas phytanic acid could be used at concen-
trations of up to 40 WM, 10 WM exposure of preadipocytes to
pristanic acid was deleterious as determined by detachment
of cells from the culture plates. Therefore, a 1 WM concen-
tration was used to compare the capacities of the fatty acids
to in£uence di¡erentiation, which was monitored by examin-
ing the appearance of brown adipocyte morphology (accumu-
lation of multivacuolar lipid droplets) and aP2 mRNA ex-
pression. 1 WM phytanic acid had a positive e¡ect on
di¡erentiation, characterized by the appearance of a low
but signi¢cant percentage of cells with the adipocyte mor-
phology (around 25%) and a 3.1 þ 0.4-fold rise (P6 0.05) in
aP2 mRNA with respect to non-treated cells, in agreement
with previous ¢ndings [8]. No signs of adipocyte di¡erentia-
tion were observed in pristanic acid-treated cells and aP2
mRNA levels were indistinguishable from non-treated cells
(0.9 þ 0.3-fold induction).
3.3. E¡ects of pristanic acid and phytanic acid on UCP1 gene
promoter activity
A second system was used to assess the potential of pris-
tanic acid to mediate the biological actions of phytanic acid in
the brown adipocytes. Previous work has shown that the gene
promoter of UCP1, the speci¢c molecular marker of di¡er-
entiated brown adipocytes, was highly sensitive to phytanic
acid [8]. To test the action of pristanic acid on the UCP1
gene promoter, the HIB-1B brown adipocyte-derived cell
line was used. HIB-1B cells were transfected with 4.5UCP1-
CAT, a plasmid in which the region 34551 to +110 of the rat
ucp-1 gene drives the CAT reporter, and exposed or not ex-
posed to each fatty acid. HIB-1B cells were treated with up to
20 WM pristanic acid with no signs of toxicity and therefore
this concentration was used for the assays as well as 5 WM.
The e¡ects of co-transfection of RXR or PPARK receptors,
potential mediators of the e¡ects of phytanic acid or pristanic
acid on gene transcription, were also determined. As shown in
Fig. 2, in the absence of co-transfected receptors, only phy-
tanic acid induced promoter activity. PPARK co-transfection
did not modify the e¡ects observed in the absence of co-trans-
fection. When RXR was co-transfected, either 5 WM or 20 WM
phytanic acid caused a signi¢cant activation of promoter ac-
tivity. In contrast, pristanic acid was ine¡ective at 5 WM and
only at 20 WM a slight but signi¢cant induction was observed.
3.4. Phytanic acid levels in brown adipose tissue. E¡ects of
cold-induced thermogenic activation
To contribute to the understanding of the potential signi¢-
cance of ¢ndings using cell cultures of brown adipocytes ex-
posed to phytanic acid, the content of these fatty acids was
determined in brown adipose tissue of adult mice. Phytanic
acid in serum from adult mice maintained in standard con-
ditions of ambient temperature and diet was 4.5 þ 0.9 WM.
Table 1 shows the content of phytanic acid in interscapular
brown adipose tissue of adult mice. To assess the capacity of
these stores to be metabolically mobilized, mice were exposed
to 4‡C for 4 h to activate the lipolysis associated with the
thermogenic activation of the tissue. As shown in Table 1,
the phytanic acid content of brown fat dropped to almost
one-half of the control levels after 4 h of cold exposure.
This drop paralleled that of total lipid content in the tissue
that decreased due to cold exposure. More than 95% of the
phytanic acid in brown adipose tissue was in the form of
triacylglycerol esters in both the control and the cold-treated
group (data not shown).
Fig. 2. E¡ects of pristanic acid and phytanic acid on UCP1 gene
promoter activity. In£uence of RXR or PPARK co-transfection.
HIB-1B cells were transiently transfected with 0.5 Wg/plate of the
4.5UCP1-CAT plasmid and were exposed to 20 WM pristanic acid
or 20 WM phytanic acid unless otherwise indicated. When indicated
0.05 Wg of the RXRK or PPARK expression vectors was co-trans-
fected. Results are expressed as fold induction of CAT activity with
respect to non-co-transfected non-treated control. Bars are means
þ S.E.M. of three independent experiments. Signi¢cant di¡erences
(P6 0.05) between the fatty acid-treated cells with respect to non-
treated cells for each set of co-transfection experiments is shown
with an asterisk.
Table 1
E¡ects of acute cold exposure on content of phytanic acid in inter-
scapular brown adipose tissue (IBAT) of mice
Control (21‡C) Cold-exposed (4‡C, 4 h)
Phytanic acid
(ng/mg tissue) 69 þ 8 38 þ 4*
(Wg/IBAT) 1.9 þ 0.2 1.1 þ 0.1*
Total lipid
(mg/100 mg tissue) 47 þ 7 25 þ 3*
(mg/IBAT) 12.8 þ 1.8 7.5 þ 0.9*
Controls were 8-week-old male mice kept at 21‡C. Cold exposure
was 4 h at 4‡C.
Results are means þ S.E.M. of six mice. *P9 0.05, statistically sig-
ni¢cant with respect to controls.
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4. Discussion
The present study shows that brown adipose tissue is a site
for high expression of PhyH mRNA, the speci¢c enzyme for
peroxisomal phytanic acid oxidation. The expression was even
higher than in the liver, the tissue considered to be a major
site for phytanic acid metabolism. Therefore, a high capacity
of phytanic acid oxidation may be expected in brown fat. A
parallel observation came from brown adipocytes in culture:
PhyH mRNA appeared as a marker of brown adipocyte dif-
ferentiation and this was not the simple re£ection of the high
peroxisomal activity associated with the brown adipocyte phe-
notype as the mRNA of COT, another peroxisomal enzyme,
which was unaltered during brown adipocyte di¡erentiation.
The induction of PhyH mRNA by phytanic acid treatment of
preadipocytes is likely to be part of the overall promotion of
brown fat di¡erentiation, although a speci¢c e¡ect cannot be
excluded on the basis of a recent report on induction of PhyH
activity by phytanic acid in several cell types [16].
The potential capacity of brown adipocytes to metabolize
phytanic acid led us to consider whether a product of its ox-
idation may be involved in its biological e¡ects. Results
showed that pristanic acid has almost no e¡ect on the markers
of brown adipocyte function and therefore neither pristanic
acid itself nor a further product of downstream metabolism of
this acid was involved in the action of phytanic acid. In fact,
pristanic acid has been shown to act in vitro through PPARK,
and PPARK activators are known to be poorly adipogenic in
white or brown di¡erentiation cell models [8,17]. Phytanic
acid can activate either RXR or PPARK and a previous study
demonstrated that the RXR-mediated pathway mediated
most of the phytanic acid e¡ects on the brown fat cell, despite
the presence of PPARK in brown adipocytes [8]. Thus, the
oxidation of phytanic acid to pristanic acid does not appear
to provide active molecules mediating phytanic acid e¡ects. In
contrast, it is expected to act as a mechanism to reduce the
phytanic acid-mediated stimulation of brown adipocytes.
Phytanic acid was present in mouse serum at a low micro-
molar range concentration, in agreement with previous ¢nd-
ings in rodents or humans [18]. Moreover, brown fat appears
as a site of phytanic acid storage, similarly to what has been
described for white adipose tissue [18]. Short-time cold expo-
sure rapidly reduces the lipid content of brown adipose tissue.
This is due to the noradrenergic-mediated activation of lipo-
lysis to provide fatty acids, which are rapidly oxidized in
mitochondria to fuel thermogenesis [19]. In this situation,
the phytanic acid content in the tissue dropped to an extent
similar to that observed for total lipids. In fact, most phytanic
acid depots in brown fat are esteri¢ed as triacylglycerols and,
when lipolysis is activated, phytanic acid is released as a free
fatty acid that is subsequently oxidized, although some may
be re-released into circulation. As a consequence of this pro-
cess, during thermogenic activation, phytanic acid may appear
transiently at a concentration higher than the serum level and
it can activate UCP1 gene transcription and contribute to
thermogenic activation in brown fat. Subsequent oxidation
leading to pristanic acid and further downstream metabolites
would down-regulate the phytanic acid-mediated e¡ects.
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